𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of continuous-infusion iproplatin (CHIP) and 5-fluorouracil (5-FU) in advanced colorectal carcinoma

✍ Scribed by Nicholas J. Petrelli; Patrick J. Creaven; Lemuel Herrera; Arnold Mittelman

Publisher
Springer
Year
1989
Tongue
English
Weight
135 KB
Volume
23
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of weekly high dose con
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

Continuous five-day infusion of pala and
Continuous five-day infusion of pala and 5FU: A pilot phase II trial
✍ Presant, Cary A. ;Ardalan, Bach ;Multhauf, Phyllis ;Chan, Clara ;Staples, Russel πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 187 KB

In order to determine whether a simultaneous infusion of N-(phospho-n-acetyl)-L-aspartic acid (PALA) was able to increase the rate of antitumor response to 5-fluorouracil (5-FU), a pilot study was conducted. Of 10 evaluable patients with previously drug-untreated colorectal carcinoma, there were onl

Bimonthly high dose leucovorin and 5-flu
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma
✍ Karine Beerblock; Yves Rinaldi; Thierry AndrΓ©; Christophe Louvet; Eric Raymond; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

with low dose LV. Based on these reports, a first-line Phase II study was performed in 101 patients with advanced colorectal carcinoma who were given a bimonthly